JP2022539329A5 - - Google Patents
Info
- Publication number
- JP2022539329A5 JP2022539329A5 JP2021576479A JP2021576479A JP2022539329A5 JP 2022539329 A5 JP2022539329 A5 JP 2022539329A5 JP 2021576479 A JP2021576479 A JP 2021576479A JP 2021576479 A JP2021576479 A JP 2021576479A JP 2022539329 A5 JP2022539329 A5 JP 2022539329A5
- Authority
- JP
- Japan
- Prior art keywords
- body weight
- days
- approximately
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/092675 | 2019-06-25 | ||
| CN2019092675 | 2019-06-25 | ||
| PCT/CN2020/097881 WO2020259528A1 (zh) | 2019-06-25 | 2020-06-24 | 治疗特发性肺纤维化的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539329A JP2022539329A (ja) | 2022-09-08 |
| JP2022539329A5 true JP2022539329A5 (enExample) | 2023-06-29 |
| JP7615061B2 JP7615061B2 (ja) | 2025-01-16 |
Family
ID=74061495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576479A Active JP7615061B2 (ja) | 2019-06-25 | 2020-06-24 | 特発性肺線維症を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12582653B2 (enExample) |
| EP (1) | EP3992183A4 (enExample) |
| JP (1) | JP7615061B2 (enExample) |
| KR (1) | KR20220029681A (enExample) |
| CN (2) | CN119868365A (enExample) |
| AU (1) | AU2020305979B2 (enExample) |
| BR (1) | BR112021026214A2 (enExample) |
| CA (1) | CA3144113A1 (enExample) |
| IL (1) | IL289192A (enExample) |
| TW (1) | TWI804743B (enExample) |
| WO (1) | WO2020259528A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230061444A (ko) * | 2020-08-31 | 2023-05-08 | 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 | Rho-연관 단백질 인산화효소 억제제의 염, 염의 고체 형태, 이의 제조 방법 및 이의 용도 |
| WO2022178420A1 (en) * | 2021-02-22 | 2022-08-25 | Graviton Bioscience Bv | Rock2 inhibitor for the treatment of viral infection |
| NO346587B1 (en) * | 2021-06-02 | 2022-10-17 | Axichem Ab | Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis |
| TW202327608A (zh) * | 2021-09-17 | 2023-07-16 | 北京泰德製藥股份有限公司 | 治療病毒感染的方法 |
| EP4393917A4 (en) * | 2021-09-18 | 2025-09-10 | Beijing Tide Pharmaceutical Co Ltd | SOLID FORM OF A RHO-ASSOCIATED PROTEIN KINASE INHIBITOR OR SOLVATE THEREOF, METHOD OF PREPARATION AND USE THEREOF |
| CN118215468A (zh) * | 2021-11-16 | 2024-06-18 | 北京泰德制药股份有限公司 | 一种rock2抑制剂的纳米晶制剂及其制备方法 |
| CN116425745B (zh) * | 2022-01-13 | 2025-06-13 | 武汉朗来科技发展有限公司 | 一种rock抑制剂的盐及盐的晶型、组合物和药物用途 |
| CN120035442A (zh) * | 2022-10-13 | 2025-05-23 | 北京泰德制药股份有限公司 | 治疗尘肺病的方法 |
| WO2025017500A1 (en) | 2023-07-17 | 2025-01-23 | Graviton Bioscience Bv | Formulations of rock2 inhibitors for cns disorders |
| WO2025017499A1 (en) | 2023-07-17 | 2025-01-23 | Graviton Bioscience Bv | Formulations and uses of rock2 inhibitors for als |
| WO2025069008A1 (en) | 2023-09-28 | 2025-04-03 | Graviton Bioscience Bv | Therapy for treating type 1 diabetes using rock2 and dyrk1 inhibitors |
| WO2025069009A1 (en) | 2023-09-29 | 2025-04-03 | Graviton Bioscience Bv | Rock2 inhibitors in the treatment of obesity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3262041A4 (en) | 2015-02-27 | 2018-08-01 | Lycera Corporation | Indazolyl thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease |
| TWI800498B (zh) * | 2016-12-21 | 2023-05-01 | 義大利商吉斯藥品公司 | 作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物 |
| JP7311228B2 (ja) * | 2017-06-30 | 2023-07-19 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Ｒｈｏ－関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用 |
| KR102563325B1 (ko) | 2017-06-30 | 2023-08-03 | 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 | Ｒｈｏ-관련 단백질 키나아제 억제제, Ｒｈｏ-관련 단백질 키나아제 억제제를 함유하는 약학 조성물, 제조 방법 및 약학 조성물의 용도 |
-
2020
- 2020-06-24 EP EP20833444.1A patent/EP3992183A4/en active Pending
- 2020-06-24 TW TW109121568A patent/TWI804743B/zh active
- 2020-06-24 WO PCT/CN2020/097881 patent/WO2020259528A1/zh not_active Ceased
- 2020-06-24 AU AU2020305979A patent/AU2020305979B2/en active Active
- 2020-06-24 US US17/621,719 patent/US12582653B2/en active Active
- 2020-06-24 KR KR1020227002368A patent/KR20220029681A/ko active Pending
- 2020-06-24 CN CN202510159677.8A patent/CN119868365A/zh active Pending
- 2020-06-24 CN CN202080045478.XA patent/CN114026072A/zh active Pending
- 2020-06-24 JP JP2021576479A patent/JP7615061B2/ja active Active
- 2020-06-24 BR BR112021026214A patent/BR112021026214A2/pt unknown
- 2020-06-24 CA CA3144113A patent/CA3144113A1/en active Pending
-
2021
- 2021-12-21 IL IL289192A patent/IL289192A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539329A5 (enExample) | ||
| JP2022522486A5 (enExample) | ||
| CN115190815B (zh) | 芳基环己基胺衍生物及其在精神障碍的治疗中的用途 | |
| JP6745726B2 (ja) | 中枢神経系障害の処置における２，４−チアゾリジンジオン誘導体 | |
| JP2019094339A (ja) | 併用療法 | |
| JP2010143934A (ja) | プルロムチリン誘導体を使用する結核症治療 | |
| EP2959903B1 (en) | Medicine for treating eye disease | |
| JP2022539329A (ja) | 特発性肺線維症を治療する方法 | |
| CA2921621C (en) | Quinine compounds, and optical isomers, preparation method and medical use thereof | |
| JP2023552610A5 (enExample) | ||
| JP7508620B2 (ja) | ジヒドロクロメン誘導体 | |
| JP2017522304A5 (enExample) | ||
| CN101511780A (zh) | 作为cpt-抑制剂的4-三甲基铵-3-氨基丁酸盐和4-三甲基-3-氨基丁酸盐衍生物 | |
| JP2023535035A5 (enExample) | ||
| EP3760616A1 (en) | 4-methyldihydropyrimidinone compound and medicinal use thereof | |
| TW202304914A (zh) | 經取代之四環羧酸、其類似物及使用其之方法 | |
| JP2005529131A (ja) | ヘリコバクターピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ）に起因する疾病を治療するためのプレウロムチリン（ｐｌｅｕｒｏｍｕｔｉｌｉｎ）の使用 | |
| JP2022531570A5 (enExample) | ||
| JP2022530890A5 (enExample) | ||
| JP2025504447A5 (enExample) | ||
| RU2013149416A (ru) | Производные камптотецина, обладающие противоопухолевой активностью | |
| KR20180054826A (ko) | Hiv 성숙 억제 활성을 갖는 화합물 | |
| JP2007500205A5 (enExample) | ||
| KR20190098253A (ko) | 모르피난 유도체, 및 자가면역, 염증 또는 감염 관련 질환을 치료하기 위한 이를 포함하는 조성물 | |
| US20240059725A1 (en) | Coumarin compounds and a process for preparation thereof |